CS Larsen - … journal of infectious diseases: IJID: official …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives The oral antiviral drugs nirmatrelvir/ritonavir (NMV/r) and molnupiravir have been
approved for early outpatient treatment of COVID-19 to prevent severe disease. Ritonavir …